Skip to main content

Advertisement

Log in

Microhook ab interno trabeculotomy for secondary glaucoma in patients with hereditary transthyretin amyloidosis

  • Clinical Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To report surgical outcomes of a Microhook ab interno trabeculotomy (µLOT) procedure for glaucoma secondary to hereditary transthyretin amyloidosis (ATTRv).

Study design

Retrospective case series.

Methods

Medical records of patients with glaucoma secondary to ATTRv with transthyretin Val30Met variant, who underwent µLOT, were retrospectively reviewed. Surgical success was categorized according to the postoperative intraocular pressures (IOPs, mmHg) as follows: (a) 6 ≤ IOP ≤ 21; (b) 6 ≤ IOP ≤ 18; and (c) 6 ≤ IOP ≤ 15, without light perception loss or additional glaucoma surgery. Secondary outcomes were glaucoma medication scores and postoperative complications.

Results

This study included 18 eyes (13 patients, 6 men). The mean follow-up period was 25.2±9.8 months (7–38 months). Kaplan–Meier analysis indicated success rates of (a) 1.00 at 6, 1.00 at 12, and 0.43 at 24 months; (b), 1.00 at 6, 0.93 at 12, and 0.43 at 24 months; (c) 0.94 at 6, 0.75 at 12, and 0.27 at 24 months after operation. Postoperative IOPs were significantly reduced from the baseline of 25.2±5.8 mmHg to 11.5±2.7 at 3, 12.3±4.1 at 6, and 13.8±3.9 at 12 months (Dunnett's test). Medication scores were also improved at 3 and 6 months but without a significant reduction at 12 months. There were no severe complications requiring surgical intervention except for additional glaucoma surgery.

Conclusion

µLOT for secondary glaucoma in ATTRv is safe and effective 1 year after surgery, but the effects diminish after 2 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig 1

Similar content being viewed by others

Data availability

The datasets analyzed during the current study are not publicly available because of the hospital’s policy to protect the personal information of the participants but are available from the corresponding author upon reasonable request.

References

  1. Adams D, Ando Y, Beirão JM, Coelho T, Gertz MA, Gillmore JD, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. 2021;268:2109–22.

    Article  Google Scholar 

  2. Schmidt HH, Waddington-Cruz M, Botteman MF, Carter JA, Chopra AS, Hopps M, et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2018;57:829–37.

    Article  CAS  Google Scholar 

  3. Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol. 1997;81:295–8.

    Article  CAS  Google Scholar 

  4. Reynolds MM, Veverka KK, Gertz MA, Dispenzieri A, Zeldenrust SR, Leung N, et al. Ocular manifestations of familial transthyretin amyloidosis. Am J Ophthalmol. 2017;183:156–62.

    Article  CAS  Google Scholar 

  5. Kakihara S, Hirano T, Matsuda Y, Takano D, Imai A, Miyahara T, et al. Deposits on retinal surface seen on OCT in ocular amyloidosis. Ophthalmol Retina. 2021;5:1005–8.

    Article  Google Scholar 

  6. Benson MD. Liver transplantation and transthyretin amyloidosis. Muscle Nerve. 2013;47:157–62.

    Article  CAS  Google Scholar 

  7. Hara R, Kawaji T, Ando E, Ohya Y, Ando Y, Tanihara H. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Arch Ophthalmol. 2010;128:206–10.

    Article  Google Scholar 

  8. Kakihara S, Hirano T, Imai A, Miyahara T, Murata T. Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis. Sci Rep. 2020;10:5574.

    Article  CAS  Google Scholar 

  9. Thiagasorupan P, Barreau E, Gendron G, Frau E, Cauquil C, Adams D, et al. Specific postoperative complications of vitrectomy in hereditary transthyretin amyloidosis. Eur J Ophthalmol. 2022;32:1149–56.

    Article  Google Scholar 

  10. Kawaji T, Inoue T, Hara R, Eiki D, Ando Y, Tanihara H. Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy. PLoS ONE. 2014;9: e96324.

    Article  Google Scholar 

  11. Kakihara S, Hirano T, Imai A, Miyahara T, Murata T. Baerveldt glaucoma drainage implant surgery for secondary glaucoma in patients with transthyretin-related familial amyloid polyneuropathy. Jpn J Ophthalmol. 2020;64:533–8.

    Article  Google Scholar 

  12. Marta A, Vieira R, Figueiredo A, Reis R, Sampaio I, Beirão JM, et al. Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis. Eye (Lond). 2022;36:111–8.

    Article  CAS  Google Scholar 

  13. Christakis PG, Zhang D, Budenz DL, Barton K, Tsai JC, Ahmed IIK. Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study. Am J Ophthalmol. 2017;176:118–26.

    Article  Google Scholar 

  14. Kasahara M, Shoji N. Effectiveness and limitations of minimally invasive glaucoma surgery targeting Schlemm’s canal. Jpn J Ophthalmol. 2021;65:6–22.

    Article  Google Scholar 

  15. Tanito M, Ikeda Y, Fujihara E. Effectiveness and safety of combined cataract surgery and microhook ab interno trabeculotomy in Japanese eyes with glaucoma: report of an initial case series. Jpn J Ophthalmol. 2017;61:457–64.

    Article  Google Scholar 

  16. Tanito M, Sano I, Ikeda Y, Fujihara E. Short-term results of microhook ab interno trabeculotomy, a novel minimally invasive glaucoma surgery in Japanese eyes: initial case series. Acta Ophthalmol. 2017;95:e354–60.

    Article  Google Scholar 

  17. Mori S, Tanito M, Shoji N, Yokoyama Y, Kameda T, Shoji T, et al. Noninferiority of microhook to trabectome: trabectome versus Ab Interno microhook trabeculotomy comparative study (tram trac study). Ophthalmol Glaucoma. 2022;5:452–61.

    Article  Google Scholar 

  18. Sotani N, Kusuhara S, Matsumiya W, Okuda M, Mori S, Sotani R, et al. Outcomes of microhook Ab Interno trabeculotomy in consecutive 36 eyes with Uveitic glaucoma. J Clin Med. 2022;11:3768.

    Article  CAS  Google Scholar 

  19. Omoto T, Fujishiro T, Asano-Shimizu K, Sugimoto K, Sakata R, Murata H, et al. Comparison of 12-month surgical outcomes of ab interno trabeculotomy with phacoemulsification between spatula-shaped and dual-blade microhooks. Jpn J Ophthalmol. 2021;65:402–8.

    Article  Google Scholar 

  20. Barbosa NB, Grippo TM. Excisional goniotomy with Kahook Dual Blade in a patient with glaucoma secondary to Transthyretin Amyloidosis. Am J Ophthalmol Case Rep. 2020;19: 100750.

    Article  Google Scholar 

  21. Scheie HG. Width and pigmentation of the angle of the anterior chamber; a system of grading by gonioscopy. AMA Arch Ophthalmol. 1957;58:510–2.

    Article  CAS  Google Scholar 

  22. Shoji N, Kasahara M, Iijima A, Takahashi M, Tatsui S, Matsumura K, et al. Short-term evaluation of Trabectome surgery performed on Japanese patients with open-angle glaucoma. Jpn J Ophthalmol. 2016;60:156–65.

    Article  CAS  Google Scholar 

  23. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379:1007–16.

    Article  CAS  Google Scholar 

  24. Adams D, Gonzalez-Duarte A, O’Riordan WD, Yang CC, Ueda M, Kristen AV, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379:11–21.

    Article  CAS  Google Scholar 

  25. Sekijima Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry. 2015;86:1036–43.

    Article  Google Scholar 

  26. Kawaji T, Ando Y, Nakamura M, Yamamoto K, Ando E, Takano A, et al. Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp Eye Res. 2005;81:306–12.

    Article  CAS  Google Scholar 

  27. Beirão NM, Matos ME, Meneres MJ, Beirão IM, Costa PP, Torres PA. Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients. Amyloid. 2012;19:146–51.

    Article  Google Scholar 

  28. Kakihara S, Hirano T, Kitahara J, Matsuda Y, Imai A, Miyahara T, et al. Ocular angiographic features in Japanese patients with val30met hereditary transthyretin amyloidosis. Retina. 2022;42:210–5.

    CAS  Google Scholar 

Download references

Acknowledgements

The authors thank the Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine for introducing patients with ATTRv to our department and the paramedical staff members in our team for helping to make this study possible. We would like to thank Editage (www.editage.com) for their writing support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinji Kakihara.

Ethics declarations

Conflicts of interest

J. Kitahara, None; S. Kakihara, None; T. Hirano, None; Y. Takahashi, None; A. Imai, None; T. Miyahara, None; T. Murata, None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Corresponding Author: Shinji Kakihara

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kitahara, J., Kakihara, S., Hirano, T. et al. Microhook ab interno trabeculotomy for secondary glaucoma in patients with hereditary transthyretin amyloidosis. Jpn J Ophthalmol 67, 84–90 (2023). https://doi.org/10.1007/s10384-022-00966-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-022-00966-5

Keywords

Navigation